Sale!

ERCC8 Gene Cockayne Syndrome Type A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ERCC8 gene plays a crucial role in the repair of DNA damage, particularly in the transcription-coupled nucleotide excision repair process. Mutations in this gene are associated with Cockayne Syndrome Type A, a rare autosomal recessive disorder characterized by growth failure, premature aging, photosensitivity, and neurological abnormalities.

A genetic test for Cockayne Syndrome Type A through the analysis of the ERCC8 gene can provide a definitive diagnosis of the condition. This test is particularly vital for individuals showing symptoms of the syndrome or those with a family history of the disorder. Early diagnosis can aid in the management of symptoms and improve the quality of life for affected individuals.

The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ERCC8 Gene Cockayne Syndrome Type A Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to identify mutations in the ERCC8 gene that are indicative of Cockayne Syndrome Type A. Given the complexity of genetic disorders and the specialized technology employed, the test price reflects the intricate processes and expertise involved in providing accurate and reliable results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ERCC8 Gene Cockayne Syndrome Type A Genetic Test

At DNA Labs UAE, we offer the ERCC8 Gene Cockayne Syndrome Type A Genetic Test at a cost of AED 4400.0.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology

Doctor and Test Department

This test is performed by our team of expert pediatricians in the Genetics department.

Pre Test Information

Prior to the ERCC8 Gene Cockayne Syndrome Type A Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the ERCC8 Gene Cockayne Syndrome Type A.

Test Details

The ERCC8 gene, also known as Excision Repair Cross-Complementation Group 8, is associated with Cockayne Syndrome Type A (CSA). CSA is a rare genetic disorder characterized by symptoms such as growth failure, intellectual disability, hearing loss, and premature aging.

NGS (Next-Generation Sequencing) genetic testing is utilized to analyze multiple genes simultaneously. In the case of the ERCC8 gene and CSA, NGS genetic testing can identify mutations or variants in the ERCC8 gene that may be responsible for the development of CSA in an individual.

The NGS genetic test for the ERCC8 gene and CSA involves obtaining a DNA sample, usually through a blood sample or cheek swab, and analyzing the DNA for any mutations or variants in the ERCC8 gene. This test is beneficial in confirming a diagnosis of CSA in individuals with suspected symptoms and can also be used for carrier testing in individuals with a family history of CSA.

It is crucial to note that genetic testing should always be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support.

Test Name ERCC8 Gene Cockayne syndrome type A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ERCC8 Gene Cockayne syndrome type A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ERCC8 Gene Cockayne syndrome type A NGS Genetic DNA Test gene ERCC8
Test Details

ERCC8 gene, also known as Excision Repair Cross-Complementation Group 8, is associated with Cockayne syndrome type A (CSA). CSA is a rare genetic disorder characterized by a variety of symptoms including growth failure, intellectual disability, hearing loss, and premature aging.

NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput sequencing technology that can analyze multiple genes simultaneously. In the context of ERCC8 gene and CSA, NGS genetic testing can identify mutations or variants in the ERCC8 gene that may be responsible for the development of CSA in an individual.

The NGS genetic test for ERCC8 gene and CSA involves obtaining a DNA sample, usually through a blood sample or cheek swab, and analyzing the DNA for any mutations or variants in the ERCC8 gene. This test can help confirm a diagnosis of CSA in individuals with suspected symptoms and can also be used for carrier testing in individuals with a family history of CSA.

It is important to note that genetic testing should always be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support.